Clinical value of ambulatory blood pressure monitoring

G. Mancia, C. Santucciu, L. Ulian, M. Gelosa, M. R. Rivolta, R. Sega

Research output: Contribution to journalArticlepeer-review


This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.

Original languageEnglish
JournalJournal of Cardiovascular Pharmacology
Issue numberSUPPL. 5
Publication statusPublished - 1994


  • ABPM
  • End-organ damage
  • Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology


Dive into the research topics of 'Clinical value of ambulatory blood pressure monitoring'. Together they form a unique fingerprint.

Cite this